Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Yum! Brands, Inc. (YUM) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Yum! Brands, Inc.Trade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Yum! Brands, Inc. vs Zimmer Biomet Holdings Inc — how do they compare? Yum! Brands, Inc. trades at $144.82 (market cap $39.02B), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Yum! Brands, Inc. is far larger — about 2.3× Zimmer Biomet Holdings Inc's market cap, and Yum! Brands, Inc. pays the higher dividend (2.1%). Which is the better fit depends on your goals — on Pluang, investors hold Yum! Brands, Inc. for 132 Days and Zimmer Biomet Holdings Inc for 89 Days on average.

YUMZBH
Market Cap
$39.02B$16.95B
Volume
2,597,6362,505,240
Sector
Consumer CyclicalHealth
52-Week High
$168.16$103.98
52-Week Low
$135.77$79.58
Typical Hold Time
132 Days89 Days
Enterprise Value
$50.63B$24.02B
Dividend Yield
2.1%1.08%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Yum! Brands, Inc.

YUM trades at $143.00, up 1.89% over 24 hours, with a bullish technical signal and strong support at $141. Revenue has grown from $6.8B in 2022 to $8.2B in 2025, with net income reaching $1.56B. Recent news highlights KFC's new Open House restaurant concept in Texas, testing expanded menus and customer experiences.

The outlook remains positive with a consensus price target of $170.44, though risks include high debt levels and competitive pressures. Earnings have beaten expectations in two of the last three quarters, with Q3 2026 results pending. Analyst sentiment is mixed with 39.22% buy ratings, 54.9% hold, and 5.88% sell.

Zimmer Biomet Holdings Inc

Zimmer Biomet (ZBH) trades at $88.91, up 0.47% today, with a bearish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23B, though net income margin declined to 8.56%. The stock is supported by a quarterly dividend of $0.24 and a consensus price target of $103.11, suggesting potential upside.

The outlook is mixed: strong fundamentals and analyst optimism contrast with technical weakness. Investment opportunities include consistent earnings beats and dividend income, but risks involve rising debt levels and competitive pressures in the medical technology sector. The stock's current valuation at a P/E of 21.57 appears reasonable if growth continues.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Yum! Brands, Inc.

Yum Brands is a U.S.-based restaurant operator featuring a portfolio of four brands: KFC (26,930 global units), Pizza Hut (18,380 units), Taco Bell (7,790 units), and The Habit Burger (310 units) at year-end 2021. With $58 billion in 2021 systemwide sales, the firm is the second-largest restaurant company in the world, behind McDonald's ($112.5 billion) but ahead of Restaurant Brands International ($36 billion) and Starbucks ($25 billion). Yum is 98% franchised, with the largest franchisee, Yum China, created via a 2016 spinoff transaction (after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity). Yum is the newest evolution of Tricon Brands, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.

Read more on YUM →

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH →